See more : PARTS iD, Inc. (ID) Income Statement Analysis – Financial Results
Complete financial analysis of Neola Medical AB (publ) (NEOLA.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neola Medical AB (publ), a leading company in the Healthcare industry within the Healthcare sector.
- Ramasigns Industries Limited (RAMASIGNS.BO) Income Statement Analysis – Financial Results
- SIG Group AG (SCBGF) Income Statement Analysis – Financial Results
- American Axle & Manufacturing Holdings, Inc. (AXL) Income Statement Analysis – Financial Results
- ALSP Orchid Acquisition Corporation I (ALORU) Income Statement Analysis – Financial Results
- Magnis Energy Technologies Limited (MNSEF) Income Statement Analysis – Financial Results
Neola Medical AB (publ) (NEOLA.ST)
About Neola Medical AB (publ)
Neola Medical AB (publ) develops medical equipment for continuous monitoring of the lungs of premature babies. It offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. NEOLA provides intensive care and healthier lives for preterm born infants. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 625.00K | 31.00K | 16.00K | 575.00K |
| Cost of Revenue | 1.43M | 571.00K | 7.98M | 7.88M | 3.18M | 1.84M |
| Gross Profit | -1.43M | -571.00K | -7.36M | -7.85M | -3.16M | -1.27M |
| Gross Profit Ratio | 0.00% | 0.00% | -1,176.96% | -25,329.03% | -19,762.50% | -220.35% |
| Research & Development | 160.00K | 200.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 11.55M | 5.36M | 1.51M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.07M | 9.62M | 11.55M | 5.36M | 1.51M | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -1.51M | 0.00 |
| Operating Expenses | 8.23M | 9.82M | 15.71M | 8.25M | 0.00 | 0.00 |
| Cost & Expenses | 9.63M | 10.39M | 7.98M | 7.88M | 3.18M | 1.84M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 1.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.43M | 571.00K | 15.00K | 7.00K | 7.00K | 7.00K |
| EBITDA | -7.58M | -9.82M | -6.64M | -6.71M | -2.60M | -754.00K |
| EBITDA Ratio | 0.00% | 0.00% | -1,174.56% | -25,306.45% | -19,718.75% | -219.13% |
| Operating Income | -9.62M | -10.39M | -7.36M | -7.85M | -3.16M | -1.27M |
| Operating Income Ratio | 0.00% | 0.00% | -1,176.96% | -25,329.03% | -19,762.50% | -220.35% |
| Total Other Income/Expenses | 611.00K | 41.00K | 703.00K | 1.14M | 556.00K | 506.00K |
| Income Before Tax | -9.01M | -10.35M | -6.65M | -6.72M | -2.61M | -761.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | -1,064.48% | -21,667.74% | -16,287.50% | -132.35% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -9.01M | -10.35M | -6.65M | -6.72M | -2.61M | -761.00K |
| Net Income Ratio | 0.00% | 0.00% | -1,064.48% | -21,667.74% | -16,287.50% | -132.35% |
| EPS | -0.16 | -0.40 | -0.37 | -0.70 | -0.15 | -0.04 |
| EPS Diluted | -0.16 | -0.40 | -0.37 | -0.70 | -0.15 | -0.04 |
| Weighted Avg Shares Out | 55.77M | 26.07M | 18.19M | 9.53M | 17.59M | 17.59M |
| Weighted Avg Shares Out (Dil) | 55.77M | 26.07M | 18.19M | 9.53M | 17.59M | 17.59M |
Source: https://incomestatements.info
Category: Stock Reports